{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"To determine the proportion of patients with relapsed multiple myeloma in whom eltrombopag maintains platelet counts at \\> 90% of baseline platelet counts with no more than 4 units of platelet transfusions at day 1 of Cycle 3 of chemotherapy","groups":[{"description":"Administration of eltrombopag to support platelets during chemotherapy\n\nEltrombopag: 100mg (patients of East Asian descent will receive a dose of 50mg) orally dosed once daily starting 6 days prior to initiation of chemotherapy for a total of 11 days of treatment during two consecutive cycles of chemotherapy","id":"OG000","title":"Migration Arm"}],"populationDescription":"Terminated with 1 patient enrolled; no data due to patient privacy.","reportingStatus":"POSTED","timeFrame":"2 years","title":"Maintenance of Platelet Count","type":"PRIMARY"}